Listed company MEI Pharma completes $100 million private placement, to be used for Litecoin strategic reserves
By: odaily.com|2025/07/23 02:11:52
Odaily News MEI Pharma announced the completion of a $100 million private placement financing, selling 29,239,767 shares of common stock or prepaid warrants of equivalent value at $3.42 per share. The proceeds will be used to establish a strategic reserve of Litecoin.
The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private placement, to join the board of directors, and designated GSR as its digital asset and fund management consultant to oversee the execution of Litecoin reserve strategy. (Businesswire)
Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025
También te puede interesar
Compartir
Ganadores
Últimas noticias sobre criptomonedas
23:52
Fed Future Meetings Risk Seeing Increased Disagreements Fueling Market Volatility
23:50
Tom Lee: BTC and ETH Risk-Reward Ratio Becoming Quite Attractive
23:48
Coinbase is now live with Rayls (RLS) spot trading
17:50
A certain whale address has deposited 10 million U into HyperLiquid, initiating a 20x ETH long position.
17:20
Coinbase to List Rayls (RLS)
Leer más
Comunitario
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]